S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|CEVA at MWC 2015: Powering a New Era of Intelligent Mobile Devices with the Industry's Leading Portfolio of Communications, Multimedia and Connectivity IPs (2015/2/18)|
|Easton Pharmaceuticals Announces Positive Updates, Changes to Its OTC Therapeutic Products, Manufacturing and North American Distributorship (2014/12/8)|
|Easton Pharmaceuticals Executes Letter of Intent and Provides Details on Green Patient Network's Business Plan (2014/12/12)|
|Easton Pharmaceuticals Finalizes and Forwards Its 2013 Audited Financials to an Existing Medical Marihuana Acquisition Target and a Health Canada Medical Marijuana for Medical Purposes (MMPR) Applicant (2014/12/1)|
|Easton Pharmaceuticals Initiates Discussions With Canadian Medical Marijuana Association / Club (2014/12/10)|
|Easton Pharmaceuticals Inc Is Pleased to Announce Definitive Finalized Agreement With Medicated Markets International LLC, a Major California Based Medical Marijuana Grower (2015/1/20)|
|Easton Pharmaceuticals Discloses List of Joint Initiatives With Medicated Markets International LLC, Its California Based Medical Marijuana Partner (2015/1/28)|
|ScottsMiracle-Gro Announces the Appointment of Brian D. Finn to Its Board of Directors (2014/12/3)|
|First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval (2014/12/3)|
|Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection (2014/12/2)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
Click above to view more mutual fund data and stats for amfe - Amfil Technologies Inc.